Diagnostic Center | June 16, 2022
Lupin Diagnostics launches its first regional reference lab in Patna
Expanding diagnostics footprint in East India
Expanding diagnostics footprint in East India
Glenmark is the first company in India to market the innovative FDC of Indacaterol
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
The product will be launched by NATCO's commercial partner Viatris.
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
Subscribe To Our Newsletter & Stay Updated
